The Senate Appropriations Committee on Wednesday (Aug. 4) voted 25-5 to send to the Senate floor a fiscal 2022 funding bill that would give FDA $3.41 billion in discretionary funding, a $200 million, or 6%, increase over fiscal 2021 levels. The bill passed out of the committee with no amendments, though some senators did raise concerns about the bill’s labeling provisions for genetically engineered salmon. Senate appropriators’ funding level for FDA is slightly lower than the nearly $3.5 billion in...